Cargando…

QOL-43. ENDOCRINE AND METABOLIC CHANGES IN CHILDREN TREATED FOR MEDULLOBLASTOMA

We examined 63 patients (40 males/23 females) after complex treatment of medulloblastoma. Patients had a median age (range) of 11.3 (5.5 ÷ 17.9) years. The median time after the end of treatment was 3.7 (1.5 ÷ 11.6) years. Endocrine disorders were detected with the following frequency: growth hormon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalinin, Alexey, Strebkova, Natalia, Zheludkova, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Neuropsychology/Quality of Life
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715952/ http://dx.doi.org/10.1093/neuonc/noaa222.700

Ejemplares similares

QOL-41. CARDIAC DYSFUNCTION IN MEDULLOBLASTOMA SURVIVORS TREATED WITH PHOTON IRRADIATION
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-06. QUALITY OF LIFE IN MEDULLOBLASTOMA SURVIVORS IN WESTERN MEXICO
por: del Campo, Regina M Navarro-Martin, et al.
Publicado: (2020)

QOL-13. Impact of hearing loss on neuropsychological functioning in children treated for medulloblastoma: A report from the Children’s Oncology Group (COG)
por: Embry, Leanne, et al.
Publicado: (2022)

QOL-01. LONGITUDINAL COMPARISON OF NEUROCOGNITIVE TRAJECTORIES IN PEDIATRIC MEDULLOBLASTOMA PATIENTS TREATED WITH PROTON VERSUS PHOTON RADIOTHERAPY
por: Kahalley, Lisa, et al.
Publicado: (2020)

QOL-15. NEURAL NETWORK INTEGRITY FOR FACIAL AFFECT RECOGNITION IN SURVIVORS OF MEDULLOBLASTOMA
por: Brinkman, Tara, et al.
Publicado: (2020)

QOL-28. NEUROCOGNITIVE PROFILE OF PEDIATRIC MEDULLOBLASTOMA PATIENTS PRIOR TO RADIATION THERAPY
por: Baig, Muhammad, et al.
Publicado: (2020)

QOL-17. Neurocognitive outcomes after treatment for medulloblastoma with reduced primary site target volume margins
por: Larkin, Trisha, et al.
Publicado: (2022)

QOL-20. IMPACT OF RADIATION DOSE AND VOLUME ON MEMORY FUNCTIONING IN CHILDREN WITH MEDULLOBLASTOMA: A REPORT FROM CHILDREN’S ONCOLOGY GROUP (COG) ACNS0331
por: Embry, Leanne, et al.
Publicado: (2020)

QOL-10. Treatment-induced leukoencephalopathy in pediatric medulloblastoma survivors and its impact on long-term neurocognitive functioning
por: Wägner, Lukas, et al.
Publicado: (2022)

QOL-11. Comparison of Neuropsychological Functioning in Pediatric Posterior Fossa Tumor Survivors: Medulloblastoma, Low-Grade Astrocytoma, and Healthy Controls
por: Levitch, Cara, et al.
Publicado: (2022)

QOL-18. A LONGITUDINAL STUDY OF NEUROCOGNITION IN CHILDREN TREATED FOR A BRAIN TUMOR
por: Lemiere, Jurgen, et al.
Publicado: (2020)

QOL-49. THE IMPACT OF OTOTOXICITY AND VISUAL IMPAIRMENT ON EDUCATION IN CHILDREN TREATED FOR CNS TUMOURS
por: Dulson, Harriet, et al.
Publicado: (2020)

QOL-13. NEUROCOGNITIVE OUTCOMES ACCORDING TO RISK-ADAPTED TREATMENT REGIMENS FOR CHILDREN OLDER THAN 4 WITH MEDULLOBLASTOMA AND POSTERIOR FOSSA EPENDYMOMA – RESULTS OF THE HIT2000 TRIAL
por: Mynarek, Martin, et al.
Publicado: (2020)

QOL-44. ASSESSMENT OF NEUROCOGNITIVE FUNCTION AND MRI PARAMETERS IN LONG-TERM SURVIVORS WITH POSTERIOR FOSSA TUMORS: A COMPARISON BETWEEN MEDULLOBLASTOMAS TREATED BY REDUCED-DOSE CRANIOSPINAL IRRADIATION AND OTHER TUMORS
por: Kagawa, Naoki, et al.
Publicado: (2020)

QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
por: Bullens, Kristien, et al.
Publicado: (2022)

QOL-19. PARENT-REPORTED COGNITIVE PROBLEMS AND DIRECT ASSESSMENT OF COGNITION IN CHILDREN TREATED FOR A BRAIN TUMOR
por: Lemiere, Jurgen, et al.
Publicado: (2020)

QOL-17. BIOLOGICAL CORRELATES OF QUALITY OF SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN MEDULLOBLASTOMA; A META-ANALYSIS OF THE SIOP-UKCCSG-PNET3 AND HIT-SIOP-PNET4 TRIALS
por: Chevignard, Mathilde, et al.
Publicado: (2020)

QOL-27. SWALLOWING ASSESSMENT IN PEDIATRIC PATIENTS WITH BRAIN TUMOR
por: Machado, Natalia Oliveira, et al.
Publicado: (2020)

QOL-24. DIFFERENTIAL IMPACT OF TUMOR LOCATION, LOCAL AND CRANIOSPINAL IRRADIATION ON NEUROPSYCHOLOGICAL LONG-TERM OUTCOME IN CHILDREN WITH MEDULLOBLASTOMA, EPENDYMOMA AND SUPRATENTORIAL PNET: A LONGITUDINAL MULTICENTER OUTCOME ASSESSMENT OF CHILDREN FROM THE HIT-2000 AND HIT-REZ TRIALS
por: Ottensmeier, Holger, et al.
Publicado: (2020)

QOL-05. TUMOR LOCATION IS LESS LIKELY INFLUENCE ON COGNITIVE DYSFUNCTION IN CHILDREN
por: Nakajima, Riho, et al.
Publicado: (2020)

QOL-56. THE RELAPSED AND OR PROGRESSED BRAIN TUMOURS IN CHILDREN: RHC, GLASGOW EXPERIENCE
por: Sastry, Jairam, et al.
Publicado: (2020)

QOL-54. HEIGHT, WEIGHT AND CARDIOVASCULAR EFFECTS OF STIMULANTS ON CHILDREN WITH BRAIN TUMOR
por: Khan, Raja, et al.
Publicado: (2020)

QOL-32. Patients treated for malignant brain tumor in the first three years of life: clinical sequelae
por: Giaquinta, Simonetta, et al.
Publicado: (2022)

QOL-33. Adaptive behaviour of patients treated for malignant brain tumor in the first three years of life
por: Giaquinta, Simonetta, et al.
Publicado: (2022)

QOL-09. SyMon-SAYS: A symptom monitoring and reporting program for children with cancer
por: Lai, Jin-Shei, et al.
Publicado: (2022)

QOL-37. USE OF COMPUTERIZED NEUROPSYCHOLOGICAL MEASURES TO ASSESS COGNITIVE MORBIDITY IN CHILDREN UNDERGOING ACTIVE RADIATION THERAPY
por: Kais, Lorri, et al.
Publicado: (2020)

QOL-02. Paediatric medical traumatic stress in children with cancer and their parents: Differences in levels of posttraumatic stress symptoms
por: Klašnja, Sandra, et al.
Publicado: (2022)

QOL-48. INTERDISCIPLINARY SPIRITUAL CARE TRAINING IN PEDIATRIC NEURO-ONCOLOGY
por: Lion, Alex, et al.
Publicado: (2020)

QOL-58. ASSESSING FATIGUE EXPERIENCED BY PEDIATRIC PATIENTS WITH INTRACRANIAL NEOPLASMS
por: Eccles, Eamon, et al.
Publicado: (2020)

QOL-36. USE OF CANNABINOIDS IN THE PEDIATRIC CENTRAL NERVOUS SYSTEM TUMOR POPULATION
por: Dorris, Kathleen, et al.
Publicado: (2020)

QOL-07. The importance of an onco-fertility program for pediatric neuro-oncology patients
por: IJgosse, Irene, et al.
Publicado: (2022)

QOL-01. Inflammatory biomarkers and psychological sequela in pediatric brain tumor survivors
por: Turner, Emily, et al.
Publicado: (2022)

QOL-29. Neuropsychology for you“ – tools to improve awareness of and access to neuropsychological care
por: Weiler-Wichtl, Liesa Josephine, et al.
Publicado: (2022)

QOL-12. Relaxation technique of imagery based story telling reduces manifestation of anxiety in children and adolescents undergoing brain tumor surgery
por: Goßler, Christina, et al.
Publicado: (2022)

QOL-30. Positive Effects of a psychological preparation program for MRI in children with cognitive issues – how to best meet the patients’ needs
por: Weiler-Wichtl, Liesa Josephine, et al.
Publicado: (2022)

QOL-07. CORTICAL VOLUME AND THICKNESS IN ADULT SURVIVORS OF CHILDHOOD POSTERIOR FOSSA TUMORS
por: Sleurs, Charlotte, et al.
Publicado: (2020)

QOL-57. SOUTHERN CALIFORNIA KAISER PERMANENTE PEDIATRIC NEURO-ONCOLOGY PROGRAM DEVELOPMENT
por: Tran, Hung
Publicado: (2020)

QOL-55. INTEGRATED MULTI-SCALE MODEL FOR PEDIATRIC BRAIN TUMOR SURVIVAL PREDICTION
por: Qiu, Yeping Lina, et al.
Publicado: (2020)

QOL-03. Beyond Survival: Clinical Rehabilitation and Functional Optimization Pearls for the Neuro-Oncologist
por: Rosenberg, Nathan
Publicado: (2022)

QOL-31. USE OF PATIENT-REPORTED OUTCOMES TO IDENTIFY YOUTH AT RISK FOR IMPAIRED OVERALL HEALTH
por: Ingerski, Lisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_891mr9mjpansp7e4vbqhe8dpp9